Q2 2026 Elekta AB (publ) Earnings Call Transcript

Nov 26, 2025 / 09:00 AM GMT

Release Date Price: $5.75 (+24.59%)

Transcript

Key Points

Positve

Elekta AB (EKTAF) reported a 1% organic growth in Q2, with strong performance in Europe showing 11% growth.
The company has a well-recognized brand and a direct sales force, allowing for better control over commercial execution.
Elekta AB (EKTAF) is the only company 100% dedicated to radiotherapy, which is a growing med tech segment.
The company has a strong R&D investment, spending 12% of revenue on innovation, supporting future best-in-class solutions.
Elekta AB (EKTAF) has a strong portfolio logic with complementary products, including the market-leading Gamma Knife and brachytherapy solutions.

Negative

Elekta AB (EKTAF) is facing challenges in the US market, with a reported 8% negative growth despite good order intake.
The company's gross margin is considered too low, having not fully recovered post-pandemic.
There is a need for a commercial turnaround in the US, and the company is not performing at full potential.
Elekta AB (EKTAF) has implemented a firmer interpretation of order criteria, leading to a cancellation of 2.2 billion in orders, predominantly affecting the Middle East and Africa region.
The company is undergoing a significant organizational restructuring, including a 10% workforce reduction, which could impact morale and operations.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EKTAb.ST - Elekta AB (publ)
Q2 2026 Elekta AB (publ) Earnings Call
Nov 26, 2025 / 09:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hi and good morning everyone, and welcome to this second quarter, investor and analyst call. My name is Peter Niquist. I'm heading up investor relations at EleCTA.

With me here, I have for the first time, our new President Jacob Joost Bomholt and welcome Jacob for the first call and hopefully many to follow.

Together with Jakob, we have our CFO Tobias Hegler.

Jacob Pibias will present the results for the second quarter, and in the fiscal year of 25,026. So we'll start off with Jacob giving some initial reflections on his first quarter as CEO, followed by a summary of the Q2 financials, including the order review announced today. Then, Tobias will go into the more details around the financials and elector's

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.